Breaking News
Investing Pro 0
👀 Bezos, Buffett & Berkowitz: What's in Their Portfolios? Unlock Data
Close

AstraZeneca PLC ADR (AZN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AstraZeneca ADR's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
72.52 +0.73    +1.02%
26/05 - Closed. Currency in USD ( Disclaimer )
After Hours
73.90
+1.38
+1.90%
19:41:34 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 3,449,742
  • Bid/Ask: 72.54 / 73.85
  • Day's Range: 72.31 - 72.90
AstraZeneca ADR 72.52 +0.73 +1.02%

AZN Income Statement

 
Featured here, the Income Statement (earnings report) for AstraZeneca PLC ADR, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/03
2022
31/12
2022
30/09
2022
30/06
Total Revenue 10879 11207 10982 10771
Revenue 10879 11207 10982 10771
Other Revenue, Total - - - -
Cost of Revenue, Total 1773 2470 2041 1829
Gross Profit 9106 8737 8941 8942
Total Operating Expenses 8192 9539 8700 8750
Selling/General/Admin. Expenses, Total 4150 4661 4332 4616
Research & Development 2308 2472 2434 2417
Depreciation / Amortization 260 -4000 3437 283
Interest Expense (Income) - Net Operating -365 -360 -339 -311
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 66 3921 -3205 -84
Operating Income 2687 1668 2282 2021
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 241 - - -
Other, Net 184 750 1360 1774
Net Income Before Taxes 2262 778 922 247
Provision for Income Taxes 458 -124 -720 -113
Net Income After Taxes 1804 902 1642 360
Minority Interest 22 21 20 19
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1803 901 1640 360
Total Extraordinary Items - - - -
Net Income 1803 901 1640 360
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 1803 901 1640 360
Dilution Adjustment -6.6 -3.22 3.05 1.2
Diluted Net Income 1809.6 904.22 1636.95 358.8
Diluted Weighted Average Shares 1560 1559 1559 1560
Diluted EPS Excluding Extraordinary Items 1.16 0.58 1.05 0.23
DPS - Common Stock Primary Issue - 1.97 - 0.93
Diluted Normalized EPS 0.961 0.559 0.784 0.693
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andre Van Laer
Andre Van Laer Mar 23, 2023 2:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why would anyone buy this thing...?
Neek Kajula
Neek Kajula Mar 24, 2022 9:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
did they develop a vaccine that works now or why is thos going up?
Hold This Sheet
Hold This Sheet Sep 23, 2021 2:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Valneva
damian del
mudlog79 Sep 20, 2021 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why this trash going up?
Pascal Torres
Pascal Torres Sep 20, 2021 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
speculation
Trader Global
Trader Global Sep 03, 2021 12:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
already breakout guy.
Adrian Vanyi
Adrian Vanyi Aug 09, 2021 2:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I would await some further drop based on the below article to come in the near future. The company did not perform well with the vaccine and i opened some short positions if my assumptions are correct.
Adrian Vanyi
Adrian Vanyi Aug 09, 2021 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://moneyweek.com/investments/stocks-and-shares/biotech-stocks/603675/astrazenecas-covid-troubles-could-see-it-pull
ray ford
ray ford Jun 30, 2021 8:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hold long = big victory ✌
Leo Mu
Leo Mu Jun 28, 2021 3:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Finally it reached $60+.
Leo Mu
Leo Mu Jun 24, 2021 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AZN and MRK: Lynparza approved in China for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. Support is strong for the 2 stocks.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email